Maxiseptic

Octenidine Dihydrochloride, the active ingredient in Maxiseptic, is an antiseptic presented as a topical preparation for cutaneous use. Together with phenoxyethanol, it provides broad‑spectrum antimicrobial activity for skin antisepsis, wound cleansing and pre‑operative skin preparation.

GNH USA supplies Maxiseptic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for import and distribution. Products are manufactured under GMP conditions and shipped with temperature‑controlled logistics where required.

Maxiseptic, an octenidine‑based antiseptic, acts on the skin and superficial wounds to provide broad‑spectrum microbial reduction, supporting infection control in several clinical contexts.

Skin antisepsis: Reduces microbial load on intact skin before invasive procedures, helping to prevent surgical site infections. Wound cleansing: Assists in cleaning contaminated superficial wounds, promoting a safer environment for healing. Pre‑operative skin preparation: Applied to the operative field to lower postoperative infection risk. Burn wound care: Used as part of a cleansing protocol for superficial burn injuries to limit bacterial colonisation.

Topical application of Maxiseptic may be associated with the following adverse reactions.

Common Side Effects: - Skin irritation: mild redness, itching or tingling that usually resolves within minutes. - Burning sensation: transient stinging or heat‑like feeling at the site of application, often brief. - Dryness: temporary loss of moisture leading to flaky skin on the treated area. - Contact dermatitis: localized allergic rash characterized by erythema, swelling and papules.

Serious or Rare Side Effects: - Anaphylaxis: rapid onset systemic allergic reaction with airway compromise, hypotension and urticaria; requires emergency care. - Chemical burn: deep tissue injury causing ulceration or necrosis if applied to damaged skin. - Severe hypersensitivity: extensive swelling, blister formation or necrotic lesions at the application site.

When using Maxiseptic, consider the following precautions to ensure safe and effective application. - Avoid application on mucous membranes: product is intended for external skin use only. - Do not apply to extensive open wounds: limit use to superficial lesions or intact skin. - Perform a patch test: discontinue if signs of allergic reaction such as rash or swelling appear. - Keep away from eyes: immediate irrigation with water is advised if accidental contact occurs. - Use with caution in patients with known hypersensitivity to octenidine or phenoxyethanol. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Maxiseptic may interact with other topical agents; the following interactions are recognised.

Major Interactions (Avoid): - Concurrent use with other strong antiseptics (e.g., chlorhexidine): increased risk of skin irritation and chemical incompatibility. - Application over topical corticosteroids: may reduce the antimicrobial efficacy of the antiseptic.

Moderate Interactions (Monitor Closely): - Co‑application with wound dressings containing silver or iodine: monitor for potential reduced activity or discoloration. - Use with alcohol‑based cosmetics or lotions: may enhance drying effect on the skin. - Simultaneous use of systemic antibiotics: no direct interaction, but monitor for additive toxicity in compromised patients.